PrEP is a way for people who do not have HIV but who are at substantial risk of getting it to prevent HIV infection by taking a pill every day. The pill (brand name Truvada) contains two medicines (tenofovir and emtricitabine) that are used in combination with other medicines to treat HIV.
The following resources have been gathered from the Centers for Disease Control & Prevention and the New York City PrEP/PEP website. All resources have been reviewed by the NH HIV Planning Group’s PrEP Workgroup and have been determined to be helpful resources for any physician electing to provide PrEP for his or her patients requesting the treatment.
- PrEP: Provider FAQs
- Printable PrEP Provider FAQs
- A Guide to Taking a Sexual History
- STD Treatment Guidelines for Adults and Adolescents
- 2015 Sexually Transmitted Diseases Treatment Guidelines
- Recommended ICD10 – CM Codes for PrEP
- Order form for PrEP Patient Education Materials
- New Hampshire STD/HIV Surveillance Data Summary Report
- New Hampshire STD/HIV/Viral Hepatitis Publications
- Enrollment form for the Gilead Prescription Assistance Program
- PrEP Clinical Trial Journal Articles